CAS No.:34521-09-0

TOXICITY DATA with REFERENCE：

1.		cyt-hmn:leu 2300 pmol/L/48H		MUREAV    Mutation Research. 16 (1972),332.
2.		ivn-hmn TDLo:79 mg/kg/3D-I		TEARAI    Terapevticheskii Archiv. Archives of Therapeutics. 34 (4)(1962),62.
3.		ipr-mus LD50:60 mg/kg		PSEBAA    Proceedings of the Society for Experimental Biology and Medicine. 129 (1968),284.
4.		scu-mus LD50:48 mg/kg		PSEBAA    Proceedings of the Society for Experimental Biology and Medicine. 129 (1968),284.
5.		ivn-mus LD50:25 mg/kg		MEIEDD    Merck Index. 10 (1983),103.

Consensus Reports：

Antimony and its compounds are on the Community Right-To-Know List.

SAFETY PROFILE：

Poison by subcutaneous, intravenous, and intraperitoneal routes. Human toxic effects by intravenous route. Human mutation data reported. See also ANTIMONY COMPOUNDS. When heated to decomposition it emits toxic fumes of Sb.
Risk Statements 20/22-51/53
R20/22:Harmful by inhalation and if swallowed. 
R51/53:Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
Safety Statements 61 
S61:Avoid release to the environment. Refer to special instructions / safety data sheets.
RIDADR 1549
RTECS CC8050000
HazardClass 6.1
PackingGroup III

Standards and Recommendations：

OSHA PEL: TWA 0.5 mg(Sb)/m³
ACGIH TLV: TWA 0.5 mg(Sb)/m³
NIOSH REL: (Antimony) TWA 0.5 mg(Sb)/m³

Analytical Methods：